Figure 5.
HER2-negative tumors belonging to the moderate-benefit group rather than no-benefit group. Distribution of HER2 FISH–positive (blank) and –negative (diagonal lines) cases according to trastuzumab benefit group.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.